Tech Company Financing Transactions
Egalet Funding Round
Egalet, operating out of Wayne, secured $14.3 million in funding from Atlas Venture, CLS Capital and Index Ventures.
Transaction Overview
Company Name
Announced On
5/8/2012
Transaction Type
Venture Equity
Amount
$14,300,000
Round
Series B
Proceeds Purpose
Egalet is moving into the final stage of testing with its lead programs of abuse-resistant pain medications.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
600 Lee Rd. 100
Wayne, PA 19087
USA
Wayne, PA 19087
USA
Phone
Website
Email Address
Overview
Egalet is a fully integrated specialty pharmaceutical company focused on developing, manufacturing and commercializing innovative pain treatments.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Todd Smith
Chief Medical Officer
Jeffrey Wilkins
Chief Operating Officer
Mark Strobeck
Vice President
Blair Clark-Schoeb
VP - Finance
Jesse Neri
VP - General Counsel
Megan Timmins
Browse more venture capital transactions:
Prev: 5/8/2012: Belly venture capital transaction
Next: 5/8/2012: Cybera venture capital transaction
Share this article
About Database of VC Transactions
We do our best to record every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs